查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1412624

In Silico临床试验市场：按治疗领域、阶段、产业划分 - 2024-2030 年全球预测

In Silico Clinical Trials Market by Therapeutic Area (Infectious Diseases, Oncology), Phase (Phase I, Phase II, Phase III), Industry - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年In Silico临床试验市场规模为30.1亿美元，预计2024年将达31.9亿美元，2030年将达到48.5亿美元，复合年增长率为7.01%。

In Silico临床试验的全球市场

主要市场统计
基准年[2023] 30.1亿美元
预测年份 [2024] 31.9亿美元
预测年份 [2030] 48.5亿美元
复合年增长率（%） 7.01%
电脑模拟临床试验市场-IMG1

FPNV定位矩阵

FPNV 定位矩阵对于评估In Silico临床试验市场至关重要。我们检视与业务策略和产品满意度相关的关键指标，以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出资讯的决策。根据评估，供应商被分为四个成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对In Silico临床试验市场中供应商的现状进行深入而深入的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献，以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外，该分析还提供了对该行业竞争特征的宝贵考察，包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。这种详细程度的提高使供应商能够做出更资讯的决策并制定有效的策略，从而在市场上获得竞争优势。

该报告对以下几个方面提供了宝贵的见解：

1-市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2-市场开拓：我们深入研究利润丰厚的新兴市场，并分析它们在成熟细分市场中的渗透率。

3- 市场多元化：提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。

4-竞争力评估与资讯：对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况、製造能力等进行全面评估。

5- 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告解决了以下关键问题：

1-In Silico临床试验市场的市场规模与预测是多少？

2-在In Silico临床试验市场的预测期内，需要考虑投资哪些产品、细分市场、应用和领域？

3-In Silico临床试验市场的技术趋势和法律规范是什么？

4-In Silico临床试验市场主要供应商的市场占有率是多少？

5-进入In Silico临床试验市场的适当型态和策略手段是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 全球慢性病盛行率上升，需要有效药物
      • 越来越需要更了解药品和设备的安全性和有效性
      • 药物研发研发费用大幅增加
    • 抑制因素
      • 新兴经济体对In Silico测验的认知较低
    • 机会
      • In Silico的进展
      • 利用先进的计算建模和模拟工具
    • 任务
      • 蛋白质弹性、分子构象和混杂性问题
  • 市场区隔分析
  • 市场趋势分析
  • 高通膨的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法律规范

第 6 章In Silico的电脑模拟临床试验市场

  • 感染疾病
  • 肿瘤学

第七章In Silico临床试验市场分阶段

  • 第一阶段
  • 第二阶段
  • 第三阶段

第 8 章In Silico临床试验市场：按行业

  • 医疗设备
  • 药品

第九章北美和南美的电脑In Silico临床试验市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第10章亚太电脑In Silico临床试验市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章欧洲、中东和非洲的In Silico临床试验市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争形势

  • FPNV定位矩阵
  • 市场占有率分析：按主要企业划分
  • 主要企业竞争情境分析

第13章竞争产品组合

  • 主要公司简介
    • Aganitha AI Inc.
    • GNS Healthcare
    • Insilico Medicine
    • InSilicoTrials Technologies
    • Instem Group of Companies
    • Labcorp Drug Development
    • Novadiscovery SAS
    • Thornton Tomasetti
    • ZMT Zurich MedTech AG
  • 主要产品系列

第十四章附录

  • 讨论指南
  • 关于许可证和定价
Product Code: MRR-742BD517F94B

[191 Pages Report] The In Silico Clinical Trials Market size was estimated at USD 3.01 billion in 2023 and expected to reach USD 3.19 billion in 2024, at a CAGR 7.01% to reach USD 4.85 billion by 2030.

Global In Silico Clinical Trials Market

KEY MARKET STATISTICS
Base Year [2023] USD 3.01 billion
Estimated Year [2024] USD 3.19 billion
Forecast Year [2030] USD 4.85 billion
CAGR (%) 7.01%
In Silico Clinical Trials Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the In Silico Clinical Trials Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the In Silico Clinical Trials Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the In Silico Clinical Trials Market, highlighting leading vendors and their innovative profiles. These include Aganitha AI Inc., GNS Healthcare, Insilico Medicine, InSilicoTrials Technologies, Instem Group of Companies, Labcorp Drug Development, Novadiscovery SAS, Thornton Tomasetti, and ZMT Zurich MedTech AG.

Market Segmentation & Coverage

This research report categorizes the In Silico Clinical Trials Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Therapeutic Area
    • Infectious Diseases
    • Oncology
  • Phase
    • Phase I
    • Phase II
    • Phase III
  • Industry
    • Medical Devices
    • Pharmaceutical
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the In Silico Clinical Trials Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the In Silico Clinical Trials Market?

3. What are the technology trends and regulatory frameworks in the In Silico Clinical Trials Market?

4. What is the market share of the leading vendors in the In Silico Clinical Trials Market?

5. Which modes and strategic moves are suitable for entering the In Silico Clinical Trials Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. In Silico Clinical Trials Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of chronic diseases worldwide and need for efficient drugs
      • 5.1.1.2. Growing need for better understanding of the safety and efficacy of a drug or a device
      • 5.1.1.3. Significant rise in R&D expenditure for drug development
    • 5.1.2. Restraints
      • 5.1.2.1. Low awareness about in silico trials in the developing economies
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in in silico clinical trials
      • 5.1.3.2. Utilization of use advanced computational modeling and simulation tools
    • 5.1.4. Challenges
      • 5.1.4.1. Issues related to protein flexibility, molecule conformation, and promiscuity
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. In Silico Clinical Trials Market, by Therapeutic Area

  • 6.1. Introduction
  • 6.2. Infectious Diseases
  • 6.3. Oncology

7. In Silico Clinical Trials Market, by Phase

  • 7.1. Introduction
  • 7.2. Phase I
  • 7.3. Phase II
  • 7.4. Phase III

8. In Silico Clinical Trials Market, by Industry

  • 8.1. Introduction
  • 8.2. Medical Devices
  • 8.3. Pharmaceutical

9. Americas In Silico Clinical Trials Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific In Silico Clinical Trials Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa In Silico Clinical Trials Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player

13. Competitive Portfolio

  • 13.1. Key Company Profiles
    • 13.1.1. Aganitha AI Inc.
    • 13.1.2. GNS Healthcare
    • 13.1.3. Insilico Medicine
    • 13.1.4. InSilicoTrials Technologies
    • 13.1.5. Instem Group of Companies
    • 13.1.6. Labcorp Drug Development
    • 13.1.7. Novadiscovery SAS
    • 13.1.8. Thornton Tomasetti
    • 13.1.9. ZMT Zurich MedTech AG
  • 13.2. Key Product Portfolio

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. IN SILICO CLINICAL TRIALS MARKET RESEARCH PROCESS
  • FIGURE 2. IN SILICO CLINICAL TRIALS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. IN SILICO CLINICAL TRIALS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. IN SILICO CLINICAL TRIALS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. IN SILICO CLINICAL TRIALS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. IN SILICO CLINICAL TRIALS MARKET DYNAMICS
  • FIGURE 7. IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2030 (%)
  • FIGURE 8. IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2023 VS 2030 (%)
  • FIGURE 10. IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2023 VS 2030 (%)
  • FIGURE 12. IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS IN SILICO CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS IN SILICO CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES IN SILICO CLINICAL TRIALS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES IN SILICO CLINICAL TRIALS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC IN SILICO CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC IN SILICO CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA IN SILICO CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA IN SILICO CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. IN SILICO CLINICAL TRIALS MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 22. IN SILICO CLINICAL TRIALS MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. IN SILICO CLINICAL TRIALS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. IN SILICO CLINICAL TRIALS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 6. IN SILICO CLINICAL TRIALS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. IN SILICO CLINICAL TRIALS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 9. IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE I, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE II, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE III, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 13. IN SILICO CLINICAL TRIALS MARKET SIZE, BY MEDICAL DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHARMACEUTICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS IN SILICO CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 19. ARGENTINA IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 20. ARGENTINA IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 21. ARGENTINA IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 22. BRAZIL IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 23. BRAZIL IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 24. BRAZIL IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 25. CANADA IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 26. CANADA IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 27. CANADA IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 28. MEXICO IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 29. MEXICO IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 30. MEXICO IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 31. UNITED STATES IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 32. UNITED STATES IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 33. UNITED STATES IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES IN SILICO CLINICAL TRIALS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 35. ASIA-PACIFIC IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 36. ASIA-PACIFIC IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 37. ASIA-PACIFIC IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC IN SILICO CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 39. AUSTRALIA IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 40. AUSTRALIA IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 41. AUSTRALIA IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 42. CHINA IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 43. CHINA IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 44. CHINA IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 45. INDIA IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 46. INDIA IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 47. INDIA IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 48. INDONESIA IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 49. INDONESIA IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 50. INDONESIA IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 51. JAPAN IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 52. JAPAN IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 53. JAPAN IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 54. MALAYSIA IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 55. MALAYSIA IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 56. MALAYSIA IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 57. PHILIPPINES IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 58. PHILIPPINES IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 59. PHILIPPINES IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 60. SINGAPORE IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 61. SINGAPORE IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 62. SINGAPORE IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 63. SOUTH KOREA IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 64. SOUTH KOREA IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 65. SOUTH KOREA IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 66. TAIWAN IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 67. TAIWAN IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 68. TAIWAN IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 69. THAILAND IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 70. THAILAND IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 71. THAILAND IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 72. VIETNAM IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 73. VIETNAM IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 74. VIETNAM IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 75. EUROPE, MIDDLE EAST & AFRICA IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 76. EUROPE, MIDDLE EAST & AFRICA IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA IN SILICO CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 79. DENMARK IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 80. DENMARK IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 81. DENMARK IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 82. EGYPT IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 83. EGYPT IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 84. EGYPT IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 85. FINLAND IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 86. FINLAND IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 87. FINLAND IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 88. FRANCE IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 89. FRANCE IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 90. FRANCE IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 91. GERMANY IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 92. GERMANY IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 93. GERMANY IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 94. ISRAEL IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 95. ISRAEL IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 96. ISRAEL IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 97. ITALY IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 98. ITALY IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 99. ITALY IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 100. NETHERLANDS IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 101. NETHERLANDS IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 102. NETHERLANDS IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 103. NIGERIA IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 104. NIGERIA IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 105. NIGERIA IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 106. NORWAY IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 107. NORWAY IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 108. NORWAY IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 109. POLAND IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 110. POLAND IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 111. POLAND IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 112. QATAR IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 113. QATAR IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 114. QATAR IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 115. RUSSIA IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 116. RUSSIA IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 117. RUSSIA IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 118. SAUDI ARABIA IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 119. SAUDI ARABIA IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 120. SAUDI ARABIA IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 121. SOUTH AFRICA IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 122. SOUTH AFRICA IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH AFRICA IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 124. SPAIN IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 125. SPAIN IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 126. SPAIN IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 127. SWEDEN IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 128. SWEDEN IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 129. SWEDEN IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 130. SWITZERLAND IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 131. SWITZERLAND IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 132. SWITZERLAND IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 133. TURKEY IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 134. TURKEY IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 135. TURKEY IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 136. UNITED ARAB EMIRATES IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 137. UNITED ARAB EMIRATES IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 138. UNITED ARAB EMIRATES IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED KINGDOM IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED KINGDOM IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED KINGDOM IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 142. IN SILICO CLINICAL TRIALS MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 143. IN SILICO CLINICAL TRIALS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 144. IN SILICO CLINICAL TRIALS MARKET LICENSE & PRICING